FDA Support for Conferences and Scientific Meetings (R13 Clinical Trial Not Allowed)
U.S. Food and Drug Administration (FDA)
Total funding amount not specified.
Grant duration until October 10, 2025.
To facilitate federal financial assistance for high-quality conferences and scientific meetings.
Focus on topics aligned with the FDA's mission and public health.
FDA components and public health stakeholders.
Reissue of PAR-19-306.
Updated to align with agency priorities.
Federal financial assistance from the FDA.
Supports conferences that address public health issues.
Recurring grant opportunity.
FDA components (e.g., CBER, CDER, CDRH, CTP, CVM, CFSAN, NCTR, OC, ORA).
Not specified.
Not specified.
Not specified.
Not specified.
Not specified.
Not specified.
Conferences and scientific meetings relevant to FDA's mission.
Public health stakeholders.
High-quality conferences and scientific meetings.
Address public health issues.
Not specified.
Not specified.
Not specified.
Total budget not specified.
Not specified.
Not specified.
April 12, 2023; October 12, 2023; April 12, 2024; October 11, 2024; April 11, 2025; October 10, 2025.
8 weeks prior to the selected application due date.
Not specified.
Letter of Intent.
Follow the SF424 (R&R) Application Guide.
Permission to submit a conference grant application does not assure funding.
Not specified.